Journal of Shandong University (Health Sciences) ›› 2023, Vol. 61 ›› Issue (7): 1-11.doi: 10.6040/j.issn.1671-7554.0.2023.0132
• 基础医学 •
JIN Shan, GAO Jie, XIE Yujiao, ZHAN Yao, DU Tiantian, WANG Chuanxin
CLC Number:
[1] Giaquinto AN, Sung H, Miller KD, et al. Breast Cancer Statistics, 2022 [J]. CA Cancer J Clin, 2022, 72(6): 524-541. [2] Islami F, Goding SA, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States [J]. CA Cancer J Clin, 2018, 68(1): 31-54. [3] Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022 [J]. CA Cancer J Clin, 2022, 72(1): 7-33. [4] Jafari SH, Saadatpour Z, Salmaninejad A, et al. Breast cancer diagnosis: Imaging techniques and biochemical markers [J]. J Cell Physiol, 2018, 233(7): 5200-5213. [5] Li G, Hu J, Hu G. Biomarker studies in early detection and prognosis of breast cancer [J]. Adv Exp Med Biol, 2017, 1026: 27-39. doi: 10.1007/978-981-10-6020-5_2. [6] 孔雪, 李娟, 段伟丽, 等. 长链非编码RNA AC012073.1对乳腺癌细胞迁移侵袭的影响及临床价值[J]. 山东大学学报(医学版), 2021, 59(4): 70-78. KONG Xue, LI Juan, DUAN Weili, et al. Effects of lncRNA AC012073.1 on the migration and invasion of human breast cancer cells and its clinical significance [J]. Journal of Shandong University(Health Sciences), 2021, 59(4): 70-78. [7] Wu Y, Wang Z, Han L, et al. PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer [J]. Mol Ther, 2022, 30(7): 2603-2617. [8] Zhang J, Fan X, Zhou Y, et al. The PRMT5-LSD1 axis confers Slug dual transcriptional activities and promotes breast cancer progression [J]. J Exp Clin Cancer Res, 2022, 41(1): 191. doi: 10.1186/s13046-022-02400-7. [9] Wu Q, Schapira M, Arrowsmith CH, et al. Protein arginine methylation: from enigmatic functions to therapeutic targeting [J]. Nat Rev Drug Discov, 2021, 20(7): 509-530. [10] Chen Y, Shao X, Zhao X, et al. Targeting protein arginine methyltransferase 5 in cancers: Roles, inhibitors and mechanisms [J]. Biomed Pharmacother, 2021, 144: 112252. doi: 10.1016/j.biopha.2021.112252. [11] Wang X, Wang C, Guan J, et al. Progress of breast cancer basic research in China [J]. Int J Biol Sci, 2021, 17(8): 2069-2079. [12] Trayes KP, Cokenakes SEH. Breast cancer treatment [J]. Am Fam Physician, 2021, 104(2): 171-178. [13] Wilkinson L, Gathani T. Understanding breast cancer as a global health concern [J]. Br J Radiol, 2022, 95(1130): 20211033. doi: 10.1259/bjr.20211033. [14] Trapani D, Ginsburg O, Fadelu T, et al. Global challenges and policy solutions in breast cancer control [J]. Cancer Treat Rev, 2022, 104: 102339. doi: 10.1016/j.ctrv.2022.102339. [15] Liu R, Gao J, Yang Y, et al. PHD finger protein 1(PHF1)is a novel reader for histone H4R3 symmetric dimethylation and coordinates with PRMT5-WDR77/CRL4B complex to promote tumorigenesis [J]. Nucleic Acids Res, 2018, 46(13): 6608-6626. [16] Wu Y, Wang Z, Zhang J, et al. Elevated expression of protein arginine methyltransferase 5 predicts the poor prognosis of breast cancer [J]. Tumour Biol, 2017, 39(4): 1010428317695917. doi: 10.1177/1010428317695917. [17] Chan-Penebre E, Kuplast KG, Majer CR, et al. A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models [J]. Nat Chem Biol, 2015, 11(6): 432-437. [18] Zhang Q, Harding R, Hou F, et al. Structural basis of the recruitment of ubiquitin-specific protease USP15 by spliceosome recycling factor SART3 [J]. J Biol Chem, 2016, 291(33): 17283-17292. [19] Long L, Thelen JP, Furgason M, et al. The U4/U6 recycling factor SART3 has histone chaperone activity and associates with USP15 to regulate H2B deubiquitination [J]. J Biol Chem, 2014, 289(13): 8916-8930. [20] Northam MR, Trujillo KM. Histone H2B mono-ubiquitylation maintains genomic integrity at stalled replication forks [J]. Nucleic Acids Res, 2016, 44(19): 9245-9255. [21] Hung SH, Wong RP, Ulrich HD, et al. Monoubiquitylation of histone H2B contributes to the bypass of DNA damage during and after DNA replication [J]. Proc Natl Acad Sci U S A, 2017, 114(11): E2205-E2214. [22] Hooda J, Novak M, Salomon MP, et al. Early loss of histone H2B monoubiquitylation alters chromatin accessibility and activates key immune pathways that facilitate progression of ovarian cancer [J]. Cancer Res, 2019, 79(4): 760-772. [23] Yeh CH, Bellon M, Nicot C. FBXW7: a critical tumor suppressor of human cancers [J]. Mol Cancer, 2018, 17(1): 115. doi: 10.1186/s12943-018-0857-2. [24] Fan J, Bellon M, Ju M, et al. Clinical significance of FBXW7 loss of function in human cancers [J]. Mol Cancer, 2022, 21(1): 87. doi: 10.1186/s12943-018-0857-2. [25] Gao J, Liu R, Feng D, et al. Snail/PRMT5/NuRD complex contributes to DNA hypermethylation in cervical cancer by TET1 inhibition [J]. Cell Death Differ, 2021, 28(9): 2818-2836. [26] Liu X, He J, Mao L, et al. EPZ015666, a selective protein arginine methyltransferase 5(PRMT5)inhibitor with an antitumour effect in retinoblastoma [J]. Exp Eye Res, 2021, 202: 108286. doi: 10.1016/j.exer.2020.108286. |
[1] | WANG Xiao-Lei, ZHANG Hai-Thao, ZHANG Hui, GUO Cheng-Hao. Protective effects of shuxuening injecta on vascular endothelial cell injury in vitro due to iodine excesses [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 38-. |
[2] | HE Jing, YAN Rugen, WU Zhihong, LI Changzhong. Effects of Xiaozheng Yiai decoction on the proliferation and migration of ovarian cancer SKOV3 cells [J]. Journal of Shandong University (Health Sciences), 2023, 61(5): 1-10. |
[3] | DONG Xiangjun, LI Juan, KONG Xue, LI Peilong, ZHAO Wenjing, LIANG Yiran, WANG Lili, DU Lutao, WANG Chuanxin. Effects of circular RNA hsa_circ_0008591 on tumor biological behavior of breast cancer cells [J]. Journal of Shandong University (Health Sciences), 2023, 61(2): 78-87. |
[4] | ZHANG Jianshu, ZHANG Hanwen, ZHAO Wenjing. LncRNA ZNF528-AS1 promotes tamoxifen resistance and progression of breast cancer [J]. Journal of Shandong University (Health Sciences), 2023, 61(1): 17-26. |
[5] | LIN Yun, XIE Yanqiu. Fertility protection and preservation in breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 42-46. |
[6] | ZHAO Ge, ZOU Cunhua, SONG Dongdong, ZHAO Shuping. Effects of tanshinone IIA on the proliferation and apoptosis of endometrial carcinoma cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 53-58. |
[7] | ZHANG Zhenwei, LI Jia, CHEN Keming. IGF2BP2/m6A/ITGA5 signal axis regulates the proliferation and migration of renal clear cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 74-84. |
[8] | HE Shiqing, LI Wanwan, DONG Shuqing, MOU Jingyi, LIU Yuying, WEI Siyu, LIU Zhao, ZHANG Jiaxin. Construction of a prognostic risk model of pyroptosis-related genes in breast cancer based on database [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 34-43. |
[9] | YANG Qifeng, ZHANG Ning. Sentinel lymph node biopsy of breast cancer in the era of precision medicine [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 1-5. |
[10] | SHEN Xiaochang, SUN Yiqing, YAN Lei, ZHAO Xingbo. Expression of aryl hydrocarbon receptor nuclear translocator-like 2 in endometrial cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 74-80. |
[11] | ZHAO Tingting, QI Yana, ZHANG Ying, YUAN Bing, HAN Mingyong. Mouse breast cancer induces changes of the microenvironment in pre-metastatic lung tissue [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 24-29. |
[12] | SONG Tian, FU Linlin, WANG Qiumin, YANG Xiao, WANG Ying, BIAN Yuehong, SHI Yuhua. Expression of fatty acid transport protein 1 in granulosa cells of patients with polycystic ovary syndrome [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 22-26. |
[13] | Yajie ZHOU,Fei WANG,Lixiang YU,Zhigang YU. Factors related to decision-making of breast-conserving surgery for female breast cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(12): 1-6. |
[14] | FENG Haigang, LIU Guowen, CAO Hong. Effects and mechanism of interfering MAD2L1 gene expression on the apoptosis of breast cancer cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(10): 9-16. |
[15] | CHU Zhuxiu, ZHAO Wenjing, LI Xiaoyan, KONG Xiaoli, MA Tingting, JIANG Liyu, YANG Qifeng. Significance of neoadjuvant chemotherapy and molecular marker changes in 218 women with breast cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 130-139. |
|